CASIA OpenIR  > 中国科学院分子影像重点实验室
A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence
Zhou, Tianjun1,2,3; Liang, Xiaolong4; Wang, Peifeng1,2,3; Hu, Yueyang1,2,3; Qi, Yafei2; Jin, Yushen5; Du, Yang2,6; Fang, Chihua1; Tian, Jie2,7
Source PublicationACS NANO
ISSN1936-0851
2020-10-27
Volume14Issue:10Pages:12679-12696
Corresponding AuthorDu, Yang(yang.du@ia.ac.cn) ; Fang, Chihua(fangch_dr@163.com) ; Tian, Jie(jie.tian@ia.ac.cn)
AbstractHepatocellular carcinoma (HCC) is a common and highly malignant tumor that is prone to recurrence and metastasis and has no effective treatment. Unsurprisingly, its prognosis is quite poor; early detection methods and effective low toxicity treatments are urgently needed. To achieve these goals, we designed a multifunctional, U.S. Food and Drug Administration-approved Prussian blue (PB) nanoparticle (NP) with a porous metal organic frame loaded with sorafenib l (SF), conjugated with HCC-specific targeting peptide SP94 and the near-infrared dye cyanine (Cy)S.S. These NPs are amenable to multimodal imaging for dynamic monitoring of their biodistribution and tumor-targeting effects. The SP94-PB-SF-Cy5.5 NPs achieved targeted delivery and controlled SF release and exhibited good photothermal effects. In this strategy, photothermal therapy and SF treatment complement each other, reducing the side effects of SF and achieving a therapeutic effect without local tumor recurrence. In addition, the catalase-like ability of l the NPs alleviates tumor hypoxia, and their photothermal effects l induce immunogenic cell death, leading to the release of tumor-associated antigens. These effects combine to trigger an antitumor immune response; the NPs also displayed promising inhibitory effects on tumor metastasis and recurrence and produced an abscopal effect and long-term immunological memory when combined with antiprogrammed death-ligand I (PD-LI) immunotherapy. These safe, multifunctional NPs represent a valuable treatment option for HCC. In addition, this next-generation treatment model may provide some ideas for the management of HCC and other cancers.
Keywordhepatocellular carcinoma prussian blue photothermal therapy sorafenib hypoxia antiprogrammed death-ligand I immunotherapy
DOI10.1021/acsnano.0c01453
WOS KeywordPRUSSIAN BLUE NANOPARTICLES ; CHECKPOINT BLOCKADE ; T-CELLS ; CANCER ; GENERATION ; IMMUNITY ; THERAPY ; SIGNALS
Indexed BySCI
Language英语
Funding ProjectNational Natural Science Foundation of China[81627805] ; National Natural Science Foundation of China[81871514] ; National Natural Science Foundation of China[81822022] ; National Natural Science Foundation of China[81771846] ; National Key Research and Development Program of China[2 0 1 7YFAO 2 0 5 2 0 0] ; National Key Research and Development Program of China[2017YFA0700401] ; National Key Research and Development Program of China[2016YFA0100902] ; National Key Research and Development Program of China[2016YFC0106500] ; Science and Technology Plan Project of Guangzhou[201604020144] ; Science and Technology Plan Project of Guangzhou[201704020141] ; NSFC-GD Union Foundation[U1401254] ; Beijing Excellent Young Talents Training Support Program[2018000021223ZK48] ; Peking University Third Hospital[BYSYZD2019018] ; Peking University Third Hospital[jyzc2018-02] ; Peking University Third Hospital[BYSY2015023]
Funding OrganizationNational Natural Science Foundation of China ; National Key Research and Development Program of China ; Science and Technology Plan Project of Guangzhou ; NSFC-GD Union Foundation ; Beijing Excellent Young Talents Training Support Program ; Peking University Third Hospital
WOS Research AreaChemistry ; Science & Technology - Other Topics ; Materials Science
WOS SubjectChemistry, Multidisciplinary ; Chemistry, Physical ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary
WOS IDWOS:000586793400026
PublisherAMER CHEMICAL SOC
Sub direction classification其他
Citation statistics
Cited Times:35[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.ia.ac.cn/handle/173211/42678
Collection中国科学院分子影像重点实验室
Corresponding AuthorDu, Yang; Fang, Chihua; Tian, Jie
Affiliation1.Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg, Guangzhou 510280, Peoples R China
2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, State Key Lab Management & Control Complex Syst, Beijing 100190, Peoples R China
3.Prov Clin & Engn Ctr Digital Med, Guangzhou 510280, Peoples R China
4.Peking Univ Third Hosp, Dept Ultrasound, Beijing 100191, Peoples R China
5.Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing 100013, Peoples R China
6.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
7.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Med, Beijing 100191, Peoples R China
First Author AffilicationInstitute of Automation, Chinese Academy of Sciences
Corresponding Author AffilicationInstitute of Automation, Chinese Academy of Sciences
Recommended Citation
GB/T 7714
Zhou, Tianjun,Liang, Xiaolong,Wang, Peifeng,et al. A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence[J]. ACS NANO,2020,14(10):12679-12696.
APA Zhou, Tianjun.,Liang, Xiaolong.,Wang, Peifeng.,Hu, Yueyang.,Qi, Yafei.,...&Tian, Jie.(2020).A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence.ACS NANO,14(10),12679-12696.
MLA Zhou, Tianjun,et al."A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence".ACS NANO 14.10(2020):12679-12696.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhou, Tianjun]'s Articles
[Liang, Xiaolong]'s Articles
[Wang, Peifeng]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhou, Tianjun]'s Articles
[Liang, Xiaolong]'s Articles
[Wang, Peifeng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhou, Tianjun]'s Articles
[Liang, Xiaolong]'s Articles
[Wang, Peifeng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.